Does DOLUTEGRAVIR\LAMIVUDINE Cause Product distribution issue? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Product distribution issue have been filed in association with DOLUTEGRAVIR\LAMIVUDINE. This represents 0.2% of all adverse event reports for DOLUTEGRAVIR\LAMIVUDINE.
7
Reports of Product distribution issue with DOLUTEGRAVIR\LAMIVUDINE
0.2%
of all DOLUTEGRAVIR\LAMIVUDINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product distribution issue From DOLUTEGRAVIR\LAMIVUDINE?
Of the 7 reports.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOLUTEGRAVIR\LAMIVUDINE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does DOLUTEGRAVIR\LAMIVUDINE Cause?
Product dose omission issue (1,089)
Inappropriate schedule of product administration (256)
Product dose omission in error (234)
Product use issue (194)
Drug ineffective (137)
Pathogen resistance (137)
Intentional dose omission (112)
Viral load increased (104)
Rash (99)
Treatment noncompliance (97)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which DOLUTEGRAVIR\LAMIVUDINE Alternatives Have Lower Product distribution issue Risk?
DOLUTEGRAVIR\LAMIVUDINE vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL
DOLUTEGRAVIR\LAMIVUDINE vs DOLUTEGRAVIR\RILPIVIRINE
DOLUTEGRAVIR\LAMIVUDINE vs DOMPERIDONE
DOLUTEGRAVIR\LAMIVUDINE vs DOMPERIDONE\PANTOPRAZOLE
DOLUTEGRAVIR\LAMIVUDINE vs DONANEMAB-AZBT